Lignans As Anticancer Agents: Recent Advances in the Discovery and Development of Lignans As Anticancer Agents - Manmeet Kaur - Grāmatas - LAP LAMBERT Academic Publishing - 9783659182242 - 2012. gada 20. augusts
Ja vāks un nosaukums nesakrīt, pareizs ir nosaukums

Lignans As Anticancer Agents: Recent Advances in the Discovery and Development of Lignans As Anticancer Agents


Saņemt e-pastu, kad prece būs pieejama
Do you have a profile? Pierakstīties
Saņemiet paziņojumus par jauniem Manmeet Kaur izdevumiem
Pievienot savam iMusic vēlmju sarakstam

Not rated yet

Cancer, an abnormal and uncontrolled cell division, has engulfed the lives of unlimited people till date. Etoposide and Teniposide are podophyllotoxin derivatives and have been used clinically for treatment of refractory testicular tumor and cancer. These compounds arrests cell growth by DNA topo II inhibition, which causes double strand breaks in DNA and known as non-interclating topo II inhibitors. They have many side effects, such as myelosuppression, poor water solubility, and the development of resistance so modification is done on it at various sites. Podophyllotoxin contains a five-ring system. Modification of the A-ring gave compounds having significant activity but less than that of Etoposide, whereas modification of the B-ring resulted in the loss of activity. E-ring is essential for its anticancer activity and D-ring in lactone form is preferred for better activity. The introduction of double bond in C-ring lowers the activity but modifications at the C-4 in C-ring with bulkier groups enhance anticancer activity. NK-611, GL-331 and Etoposide phosphate are water soluble derivatives of Etoposide with potent anticancer activity and are currently in clinical trials.

Mediji Grāmatas     Paperback Book   (Grāmata ar mīksto vāku un līmēto muguru)
Izlaists 2012. gada 20. augusts
ISBN13 9783659182242
Izdevēji LAP LAMBERT Academic Publishing
Lapas 184
Izmēri 150 × 11 × 226 mm   ·   276 g
Valoda Angļu  

Vairāk no Manmeet Kaur

Rādīt visu